CRIS Current Research Information System

GRIGIONI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.280
EU - Europa 6.625
AS - Asia 6.504
AF - Africa 390
SA - Sud America 326
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
Totale 22.144
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.182
VN - Vietnam 2.115
IT - Italia 1.874
SG - Singapore 1.691
CN - Cina 1.517
GB - Regno Unito 1.417
DE - Germania 779
SE - Svezia 702
FR - Francia 383
HK - Hong Kong 383
UA - Ucraina 364
RU - Federazione Russa 301
IN - India 298
BR - Brasile 229
IE - Irlanda 214
NL - Olanda 156
ZA - Sudafrica 125
JP - Giappone 116
EE - Estonia 112
FI - Finlandia 91
TG - Togo 88
CA - Canada 64
CI - Costa d'Avorio 62
BG - Bulgaria 61
JO - Giordania 60
PH - Filippine 54
NG - Nigeria 47
AR - Argentina 46
KR - Corea 43
BD - Bangladesh 42
SC - Seychelles 35
CH - Svizzera 34
BE - Belgio 32
TH - Thailandia 26
AT - Austria 24
IR - Iran 24
PL - Polonia 21
MX - Messico 17
PK - Pakistan 17
TW - Taiwan 17
IQ - Iraq 15
TR - Turchia 15
ES - Italia 14
ID - Indonesia 14
AU - Australia 12
GR - Grecia 12
LB - Libano 12
CL - Cile 11
EC - Ecuador 11
UZ - Uzbekistan 11
CO - Colombia 9
MA - Marocco 9
AE - Emirati Arabi Uniti 8
SA - Arabia Saudita 8
EU - Europa 7
KE - Kenya 7
PY - Paraguay 7
LT - Lituania 6
UY - Uruguay 6
AZ - Azerbaigian 4
DZ - Algeria 4
EG - Egitto 4
PT - Portogallo 4
RO - Romania 4
VE - Venezuela 4
CZ - Repubblica Ceca 3
JM - Giamaica 3
OM - Oman 3
PE - Perù 3
AL - Albania 2
BY - Bielorussia 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
LY - Libia 2
MY - Malesia 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
BB - Barbados 1
CY - Cipro 1
GD - Grenada 1
HN - Honduras 1
HT - Haiti 1
KG - Kirghizistan 1
KH - Cambogia 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
MZ - Mozambico 1
NO - Norvegia 1
PA - Panama 1
Totale 22.141
Salva come PNG Salva come JPEG
Città #
Southend 1.242
Singapore 1.165
Ashburn 903
Fairfield 839
San Jose 521
Chandler 483
Woodbridge 472
Ho Chi Minh City 443
Wilmington 436
Houston 412
Seattle 404
Hanoi 399
Hong Kong 368
Santa Clara 318
Cambridge 297
Dong Ket 292
Princeton 292
Ann Arbor 264
Jacksonville 226
Beijing 214
Dublin 213
Boardman 180
Milan 177
Padova 151
Nanjing 150
Bologna 140
Lauterbourg 134
Westminster 133
Rome 115
New York 109
Tokyo 105
Berlin 98
Los Angeles 94
Lomé 88
Helsinki 82
Bremen 77
Buffalo 76
Jinan 74
Shenyang 73
Dallas 68
Hefei 68
Haiphong 65
Abidjan 62
Saint Petersburg 62
Turin 62
Amman 60
Sofia 60
Da Nang 56
Changsha 53
Abeokuta 45
Medford 45
Munich 45
San Diego 45
Frankfurt am Main 43
Zhengzhou 43
Florence 42
Guangzhou 42
Hebei 40
Mülheim 40
Nanchang 40
Naples 37
Tianjin 36
Redondo Beach 35
Dearborn 33
Shanghai 33
São Paulo 33
Verona 31
Jiaxing 30
Brussels 29
Bari 26
London 25
Mahé 23
Bern 22
Biên Hòa 22
Falkenstein 22
Hangzhou 21
Quận Bình Thạnh 21
Redwood City 21
Hải Dương 20
Ningbo 20
Chicago 19
Toronto 19
Des Moines 18
Thái Nguyên 18
Can Tho 17
Council Bluffs 17
Falls Church 17
Olalla 17
Seoul 17
Yubileyny 17
Bắc Ninh 16
Taizhou 16
Johannesburg 15
The Dalles 15
Catania 14
Nuremberg 14
Trento 14
Vienna 14
Vinh 14
Ancona 13
Totale 14.206
Salva come PNG Salva come JPEG
Nome #
Valutazione italiana del "Minnesota Living with Heart Failure Questionnaire" 1.378
Acute heart failure in patients with acute aortic syndrome: Pathophysiology and clinical-prognostic implications 318
Sicurezza dell'utilizzo delle statine nel paziente trapiantato di cuore:16 anni di esperienza clinica. 316
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 309
First-in-man implantation of a tricuspid annular remodeling device for functional tricuspid regurgitation 281
Changes in exercise capacity induced by heart transplantation: prognostic and therapeutic implications. 251
Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: Epidemiology, risk factors, and outcomes 244
Nonobstructive versus obstructive coronary artery disease in acute coronary syndrome: A meta-analysis 240
Prognostic stratification and treatment of cardiac light chain amyloidosis: a narrow path in the jungle. 238
Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies 227
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective 219
Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: Towards tailoring of therapeutic strategies? 210
Assessment of mitral regurgitation through Doppler echocardiography: Feasibility, pitfalls and diagnostic advantages 203
Le complicanze metaboliche post-trapianto di cuore ruolo dell'adiponectina ed associazione con la malattia coronarica del graft 202
Monitoring of CMV-specific cell-mediated immunity in heart transplant recipients: clinical utility of the QuantiFERON®-CMV assay for the management of post-transplant CMV infection 202
Electrocardiographic remodeling during cardiac resynchronization therapy 200
Histological and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy. A Clinical-Pathological Study of 30 Explanted Hearts 198
Age and heart transplantation: results from a heart failure management unit. 195
Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure. 193
Unusual rapid evolution of type B aortic dissection in a Marfan patient following heart transplantation: successful endovascular treatment. 193
Post-operative pleural effusion in a heart transplant recipient: A singlecase study of physiotherapy treatment 192
Cardiac transplantation from a carbon monoxide intoxicated donor. 192
Diagnosi non invasiva di rigetto miocardico acuto: l'analisi armonica dell'ecg coadiuva la valutazione clinica 191
Clinical use of doppler echocardiography in organic mitral regurgitation: From diagnosis to patients’ management 191
Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center 190
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation 188
Static and dynamic predictors of adverse events in patients with intermediate cardiopulmonary capacity referred for heart transplantation. 185
Clinical outcome after surgical correction of mitral regurgitation due to papillary muscle rupture. 184
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: Long-term follow-up of the SHIRAKISS randomized, prospective study. 184
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 184
Defining the diagnosis in echocardiographically suspected senile systemic amyloidosis. 184
Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice. 182
Relationship between psychiatric disorders and physical status during the course of a heart transplantation program: a prospective, longitudinal study. 181
Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation 180
Implantation of cardioverter-defibrillator: Effects on shoulder function. 179
Influence of the MELD-XI (Model of End-Stage Liver Disease Excluding INR) on Heart Transplant Outcomes 179
Impact of Pre-Transplant Pulmonary Hypertension Grading on Early- to Long-Term Hemodynamics, Right Venticular Graft Function and Survival After Heart Transplantation 179
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 178
Prognostic stratification of women with chronic heart failure referred for heart transplantation: relevance of gender as compared with gender-related characteristics. 177
Role of Intra-Aortic Balloon Pump and Extracorporeal Membrane Oxygenation in Early Graft Failure After Cardiac Transplantation 175
Clinical and Prognostic Correlates of pAMR Grading in Patients with Suspect Antibody Mediated Rejection 174
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 173
EVEROLIMUS REDUCES CAV PROGRESSION AS COMPARED WITH AZATHIOPRINE AND MYCOPHENOLATE: A LONGITUDINAL IVUS- BASED STUDY 170
Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells. 170
Qualità della vita e parametri clinico-strumentali nello scompenso cardiaco. 169
Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure? 169
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 167
Efficacia del trattamento a lungo termine con statine nel paziente trapiantato di cuore. 165
Cyclosporine lowering with everolimus or mycophenolate to preserve renal function in heart recipients: a randomized study. 164
Ruolo dell'NT-proBNP nella stratificazione prognostica dei pazienti con scompenso cardiaco cronico. 163
Il rallentamento del flusso di perfusione coronarica valutato con il TIMI frame count è in grado di predire la mortalità a lungo termine nei pazienti con trapianto di cuore 163
Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long-term outcome study 163
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 162
PREDICTING CARDIOVASCULAR OUTCOMES LONG-TERM AFTER HEART TRANSPLANT BY LATE CHANGES IN MAXIMAL INTIMAL THICKNESS: BEYOND THE HYSTORICAL 1-YEAR LIMIT 162
Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients 161
Multimodality imaging of the tricuspid valve with implication for percutaneous repair approaches 161
Prophylaxis versus preemptive therapy for prevention of the consequences of cytomegalovirus infection in transplant recipients: a still unresolved issue 160
Association Between Early Surgical Intervention vs Watchful Waiting and Outcomes for Mitral Regurgitation Due to Flail Mitral Valve Leaflets 160
Prophylaxis vs. Pre-Emptive Strategies in Preventing Cytomegalovirus-Dependent Cardiac Allograft Vasculopathy 159
Efficacia e sicurezza dell'ezetimibe in associazione con basse dosi di simvastatina per il trattamento dell'iperlipidemia post-trapianto cardiaco 157
Reproducibility of IVUS Measurements in Heart Transplant Recipients: Increased Quality of Data by Using Dedicated Software for Image Analysis 156
Predicting Right Ventricular Failure in the Current Continuous Flow Left Ventricular Assist Device Era 155
Role of severe functional mitral regurgitation in predicting electrical remodeling in idiopathic dilated cardiomyopathy. 154
PRE-TRANSPLANT NON-CYTOTOXIC ANTI-HLA ANTIBODIES PREDICT MULTIPLE ADVERSE EVENTS AFTER HEART TRANSPLANTATION 153
Homocysteine-lowering therapy and early progression of transplant vasculopathy: a prospective, randomized, IVUS-based study. 153
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 152
EURObservational Research Programme: Regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot) 152
Pre-Transplant Non-Cytotoxic Anti-HLA Antibodies Predict Multiple Adverse Events after Heart Transplantation 152
Correlazione tra metodi semiquantitativi e quantitativi nella valutazione dell'insufficienza mitralica organica ed associazione con test da sforzo cardiopolmonare e pro-BNP 149
RotaFlow and CentriMag Extracorporeal Membrane Oxygenation Support Systems as Treatment Strategies for Refractory Cardiogenic Shock 149
Comparative effectiveness of disease-modifying-drugs in elderly patients after incident hospitalization for heart failure 149
Left Atrial Size is a Potent Predictor of Mortality in Mitral Regurgitation Due to Flail Leaflets: Results from a Large International Multicenter Study. 149
L'infezione da citomegalovirus e i parametri indicativi di insulino-resistenza influenzano in modo distinto e specifico le variazioni nella geometria coronarica nel primo anno dopo trapianto di cuore 149
Heart transplantation in hypertrophic cardiomyopathy. 148
Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection 147
Cardiovascular prevention in HIV-positive individuals on antiretroviral therapy.. The paradigm shift has already happened: Is it time to wake up and realise it? 146
Long-term mortality associated with left ventricular dysfunction in mitral regurgitation due to flail leaflets: A multicenter analysis 146
Interplay between Pulmonary Hypertension and Donor-Recipient Matching in the Risk for Early Graft Failure after Heart Transplantation 145
Cardiac resynchronization by pacing: an electrical treatment of heart failure 145
Relevance of cardioverter defibrillators for the prevention of sudden cardiac death on the timing of heart transplantation. 145
The risk of right ventricular failure with current continuous-flow left ventricular assist devices 144
Late Changes in Maximal Intimal Thickness after Heart Transplant: Prognostic Implications and Risk Factors 143
Impact of ageing on presentation and outcome of mitral regurgitation due to flail leaflet: a multicentre international study 143
Prevalence of substance-related disorders in heart transplantation candidates 142
Letter by Boriani et al regarding article, "Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study". 141
Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction. 141
Extracorporeal Membrane Oxygenation Support in Refractory Cardiogenic Shock: Treatment Strategies and Analysis of Risk Factors 141
Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: A Multicenter Long-term International Study 140
Atrial fibrillation, vascular phenotype, APOE genotype and Alzheimer's Disease: a perspective cohort study 140
Management of asymptomatic mitral regurgitation. 139
SAFETY AND EFFICACY OF TWO TYPES OF INFLUENZA VACCINATION IN HEART TRANSPLANT RECIPIENTS: A PROSPECTIVE RANDOMISED CONTROLLED STUDY 138
Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome 137
Outcomes in mitral regurgitation due to flail leaflets a multicenter European study. 136
Insufficienza mitralica organica: parametri ecocardiografici, funzionali e neuro-ormonali potenziali predittori di intervento chirurgico a breve termine 136
Extracorporeal Membrane Oxygenation Support System as Bridge to Solution in Refractory Cardiogenic Shock 135
L'infezione subclinica da citomegalovirus modula l'infiammazione sistemica e il rimodellamento coronarico ad un anno dal trapianto. 135
Evaluation of postural disorders in patients pre and post heart transplant. 134
Quantitation of mitral regurgitation 133
Potential of medical treatment, device therapy, and conventional surgery in patients referred for heart transplantation. 133
Use of Mechanical Circulatory Support Devices in End-Stage Heart Failure Patients 131
Totale 18.540
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.190
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021602 0 0 0 0 0 0 0 0 0 0 0 602
2021/20222.521 205 113 169 316 225 139 59 158 110 191 430 406
2022/20232.649 259 362 157 341 205 208 78 136 458 101 212 132
2023/2024819 65 122 42 96 58 167 38 34 31 67 55 44
2024/20252.790 153 435 235 220 506 137 156 106 49 201 69 523
2025/20266.243 827 444 497 365 724 354 563 405 1.305 458 203 98
Totale 22.481